首页> 外国专利> INHALATION PREPARATION ARRESTING ASPHYXIA IN BRONCHIAL ASTHMA AND BRONCHIAL SPASM

INHALATION PREPARATION ARRESTING ASPHYXIA IN BRONCHIAL ASTHMA AND BRONCHIAL SPASM

机译:支气管哮喘和支气管痉挛的吸入制剂预防窒息

摘要

FIELD: medicine, microbiology. SUBSTANCE: invention relates to a medicinal preparation prepared from the strain Staphylococcus aureus C2 GISK N 222 after preliminary the development stage. An agent shows biological activity 19%, not less, by an index of elimination of an inflammatory response containing protein in concentration 0.0063-0.063 mg/ml in an inhalation form and providing a size of inhaling particles 2-5 mcm that ensures to treat diseases affecting low respiratory ways bronchi, bronchioles, alveoles, in part, bronchial asthma. The preparation has a low protein load on patient and in distinction with other similar preparations has nonhormonal origin. EFFECT: enhanced effectiveness of agent, valuable medicinal properties. 3 tbl, 2 ex
机译:领域:医学,微生物学。本发明涉及从金黄色葡萄球菌C2 GISK N 222菌株经过初步开发阶段制备的药物制剂。一种药剂通过消除炎症反应的指数显示出19%的生物活性,而该炎症反应的浓度为0.0063-0.063 mg / ml的可吸入形式的蛋白质,并提供2-5 mcm大小的可确保治疗疾病的吸入颗粒影响下呼吸道的支气管,细支气管,肺泡,部分影响支气管哮喘。该制剂对患者的蛋白质负荷低,并且与其他类似制剂不同,具有非激素来源。效果:增强了药剂的功效,有价值的药用特性。 3汤匙,2前

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号